secwatch.observer — SEC 8-K summary
======================================

Issuer:     Kezar Life Sciences, Inc. (KZR)
CIK:        0001645666
Form:       8-K
Filed at:   2021-12-10T23:59:59+00:00
Accession:  0001564590-21-060020
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Kezar Life Sciences appoints Courtney Wallace to board; director Jason Dinges resigns
--------------------------------------------------------------------------------

- Jason Dinges, Ph.D., resigned from the board effective Dec 9, 2021; departure not due to disagreement.
- Courtney Wallace appointed as Class I director, serving until 2022 annual meeting or successor.
- Wallace receives annual cash compensation of $35,000 plus initial option for 52,000 shares vesting monthly over 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645666/000156459021060020/0001564590-21-060020-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645666/000156459021060020/kzr-8k_20211209.htm
  HTML page:      https://secwatch.observer/filing/0001564590-21-060020

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer